Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013–2018

We investigated the prevalence of azole resistance of Aspergillus fumigatus isolates in the Netherlands by screening clinical A. fumigatus isolates for azole resistance during 2013–2018. We analyzed azole-resistant isolates phenotypically by in vitro susceptibility testing and for the presence of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lestrade, Pieter P.A., Buil, Jochem B., van der Beek, Martha T., Kuijper, Ed J., van Dijk, Karin, Kampinga, Greetje A., Rijnders, Bart J.A., Vonk, Alieke G., de Greeff, Sabine C., Schoffelen, Annelot F., van Dissel, Jaap, Meis, Jacques F., Melchers, Willem J.G., Verweij, Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323544/
https://www.ncbi.nlm.nih.gov/pubmed/32568033
http://dx.doi.org/10.3201/eid2607.200088
Descripción
Sumario:We investigated the prevalence of azole resistance of Aspergillus fumigatus isolates in the Netherlands by screening clinical A. fumigatus isolates for azole resistance during 2013–2018. We analyzed azole-resistant isolates phenotypically by in vitro susceptibility testing and for the presence of resistance mutations in the Cyp51A gene. Over the 6-year period, 508 (11%) of 4,496 culture-positive patients harbored an azole-resistant isolate. Resistance frequency increased from 7.6% (95% CI 5.9%–9.8%) in 2013 (58/760 patients) to 14.7% (95% CI 12.3%–17.4%) in 2018 (112/764 patients) (p = 0.0001). TR(34)/L98H (69%) and TR(46)/Y121F/T289A (17%) accounted for 86% of Cyp51A mutations. However, the mean voriconazole MIC of TR(34)/L98H isolates decreased from 8 mg/L (2013) to 2 mg/L (2018), and the voriconazole-resistance frequency was 34% lower in 2018 than in 2013 (p = 0.0001). Our survey showed changing azole phenotypes in TR(34)/L98H isolates, which hampers the use of current PCR-based resistance tests.

Ejemplares similares